CLIA-waived molecular influenza testing in the emergency department and outpatient settings.
暂无分享,去创建一个
[1] K. Coley,et al. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists , 2018, Journal of pharmacy practice.
[2] F. Hassan,et al. Multicenter evaluation of the Alere™ i influenza A&B assay using respiratory specimens collected in viral transport media. , 2018, Diagnostic microbiology and infectious disease.
[3] F. Hassan,et al. Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from Children , 2018, Journal of Clinical Microbiology.
[4] J. Gooding,et al. Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection , 2018, Reviews in medical virology.
[5] D. Green,et al. Rapid Antigen Tests for Influenza: Rationale and Significance of the FDA Reclassification , 2018, Journal of Clinical Microbiology.
[6] M. Landry,et al. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests , 2018, Journal of Clinical Microbiology.
[7] Yi-Wei Tang,et al. Parallel Validation of Three Molecular Devices for Simultaneous Detection and Identification of Influenza A and B and Respiratory Syncytial Viruses , 2017, Journal of Clinical Microbiology.
[8] J. H. Chen,et al. Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses. , 2017, Diagnostic microbiology and infectious disease.
[9] S. Mace,et al. Multi-center evaluation of the cobas® Liat® Influenza A/B & RSV assay for rapid point of care diagnosis. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] F. Nolte,et al. Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection , 2016, Journal of Clinical Microbiology.
[11] N. E. Babady,et al. Hospital-Associated Infections , 2016, Microbiology spectrum.
[12] D. Klepser,et al. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States , 2016, Expert review of molecular diagnostics.
[13] Matthew J. Binnicker,et al. Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay , 2015, Journal of Clinical Microbiology.
[14] H. Hirsch,et al. Diagnostic performance of near-patient testing for influenza , 2015, Journal of Clinical Virology.
[15] K. Rooney,et al. Point-of-care testing in the overcrowded emergency department – can it make a difference? , 2014, Critical Care.
[16] Anne Elixhauser,et al. Trends in Emergency Department Visits, 2006–2011 , 2014 .
[17] D. Cohen,et al. Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] Daniel J. Shapiro,et al. A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. , 2014, Journal of the Pediatric Infectious Diseases Society.
[19] T. Uyeki,et al. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] A. Duppenthaler,et al. Impact of the Availability of an Influenza Virus Rapid Antigen Test on Diagnostic Decision Making in a Pediatric Emergency Department , 2013, Pediatric emergency care.
[21] Madhukar Pai,et al. Accuracy of Rapid Influenza Diagnostic Tests , 2012, Annals of Internal Medicine.
[22] L. Gubareva,et al. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[23] E. Ozkaya,et al. The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department , 2009, Acta paediatrica.
[24] T. Uyeki,et al. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[25] Stefan Gravenstein,et al. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] K. Deichmann,et al. Effect of rapid influenza testing on the clinical management of paediatric influenza , 2009, Influenza and other respiratory viruses.
[27] J. Benito-Fernández,et al. Impact of Rapid Viral Testing for Influenza A and B Viruses on Management of Febrile Infants Without Signs of Focal Infection , 2006, The Pediatric infectious disease journal.
[28] K. Poehling,et al. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. , 2006, Archives of pediatrics & adolescent medicine.
[29] V. Sharma,et al. Impact of Rapid Influenza Testing at Triage on Management of Febrile Infants and Young Children , 2006, Pediatric emergency care.
[30] T. F. Smith,et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing , 2006, Clinical Microbiology Reviews.
[31] K. Lewandrowski. POC testing in the emergency department : Strategies to improve clinical and operational outcomes October 2011 , 2017 .